|Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial|
LA Guay, P Musoke, T Fleming, D Bagenda, M Allen, C Nakabiito, ...
The Lancet 354 (9181), 795-802, 1999
|Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission|
PM Garcia, LA Kalish, J Pitt, H Minkoff, TC Quinn, SK Burchett, J Kornegay, ...
New England Journal of Medicine 341 (6), 394-402, 1999
|Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the …|
JB Jackson, P Musoke, T Fleming, LA Guay, D Bagenda, M Allen, ...
The Lancet 362 (9387), 859-868, 2003
|The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter|
DA Katzenstein, SM Hammer, MD Hughes, H Gundacker, JB Jackson, ...
New England Journal of Medicine 335 (15), 1091-1098, 1996
|Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)|
SH Eshleman, M Mracna, LA Guay, M Deseyve, S Cunningham, ...
Aids 15 (15), 1951-1957, 2001
|Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection|
JM Jacobson, JS Greenspan, J Spritzler, N Ketter, JL Fahey, JB Jackson, ...
New England Journal of Medicine 336 (21), 1487-1493, 1997
|Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART|
RE Nettles, TL Kieffer, P Kwon, D Monie, Y Han, T Parsons, ...
Jama 293 (7), 817-829, 2005
|Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection|
CW Hendrix, AC Collier, MM Lederman, D Schols, RB Pollard, S Brown, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (2), 1253-1262, 2004
|Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa|
E Marseille, JG Kahn, F Mmiro, L Guay, P Musoke, MG Fowler, ...
The Lancet 354 (9181), 803-809, 1999
|Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission|
JB Jackson, G Becker-Pergola, LA Guay, P Musoke, M Mracna, ...
Aids 14 (11), F111-F115, 2000
|A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)|
P Musoke, LA Guay, D Bagenda, M Mirochnick, C Nakabiito, T Fleming, ...
Aids 13 (4), 479-486, 1999
|Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the …|
T Flys, DV Nissley, CW Claasen, D Jones, C Shi, LA Guay, P Musoke, ...
The Journal of infectious diseases 192 (1), 24-29, 2005
|Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP|
SH Eshleman, DR Hoover, S Chen, SE Hudelson, LA Guay, A Mwatha, ...
The Journal of infectious diseases 192 (1), 30-36, 2005
|Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection|
RW Coombs, SL Welles, C Hooper, PA Reichelderfer, RT D'Aquila, ...
Journal of Infectious Diseases 174 (4), 704-712, 1996
|Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations|
W Huang, SH Eshleman, J Toma, S Fransen, E Stawiski, EE Paxinos, ...
Journal of virology 81 (15), 7885-7893, 2007
|HIV-Infektion und AIDS-Erkrankung|
H Busch, S Christensen, C Weishaupt
Drogen, 143-159, 2000
|Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability|
D Brambilla, C Jennings, G Aldrovandi, J Bremer, AM Comeau, ...
Journal of Clinical Microbiology 41 (5), 1888-1893, 2003
|Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled …|
The Lancet 372 (9635), 300-313, 2008
|Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories.|
B Yen-Lieberman, D Brambilla, B Jackson, J Bremer, R Coombs, ...
Journal of Clinical Microbiology 34 (11), 2695-2701, 1996
|Absence of HIV infection in blood donors with indeterminate Western blot tests for antibody to HIV-1|
JB Jackson, KL MacDonald, J Cadwell, C Sullivan, WE Kline, M Hanson, ...
New England Journal of Medicine 322 (4), 217-222, 1990